Immortality gene mutation identifies brain tumors and other cancers (DukeHealth.org)
Mar. 18, 2013
Newly identified mutations in a gene that makes cells immortal appear to play a pivotal role in three of the most common types of brain tumors, as well as cancers of the liver, tongue and urinary tract, according to research led by Duke Cancer Institute.
Sickle Cells Show Potential to Attack Aggressive Cancer Tumors (DukeHealth.org)
Jan. 9, 2013
By harnessing the very qualities that make sickle cell disease a lethal blood disorder, a research team led by Duke Medicine and Jenomic, a private cancer research company in Carmel, Calif., has developed a way to deploy the misshapen red blood cells to fight cancer tumors.
New Breast Cancer Drug Halts Tumor Growth Better Than Standard Therapy (DukeHealth.org)
June 4, 2012
A new cancer treatment that links chemotherapy with an agent that homes in on specific breast cancer cells was significantly better than the current drug regimen at keeping patients' advanced tumors from progressing, according to results from a Phase III clinical trial led by Kimberly Blackwell, M.D., of the Duke Cancer Institute.
Experts Identify Critical Genes Mutated in Stomach Cancer (DukeHealth.org)
Apr. 9, 2012
An international team of scientists, led by researchers from the Duke-NUS Graduate Medical School (Duke-NUS) in Singapore and National Cancer Centre of Singapore, has identified hundreds of novel genes that are mutated in stomach cancer, the second-most lethal cancer worldwide.
Discovery Could Reduce Chemotherapy's Side Effects (DukeHealth.org)
Mar. 11, 2012
A team of researchers at Duke University has determined the structure of a key molecule that can carry chemotherapy and anti-viral drugs into cells, which could help to create more effective drugs with fewer effects to healthy tissue.